{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:26:24Z","timestamp":1760297184897},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.ophtha.2003.08.028","type":"journal-article","created":{"date-parts":[[2004,5,4]],"date-time":"2004-05-04T12:29:33Z","timestamp":1083673773000},"page":"940-945","source":"Crossref","is-referenced-by-count":33,"title":["Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion"],"prefix":"10.1016","volume":"111","author":[{"given":"Lorenzo","family":"Di Crecchio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio Battaglia","family":"Parodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Sanguinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Iacono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Ravalico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2003.08.028_BIB1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0039-6257(93)90138-W","article-title":"Central retinal vein occlusion in young adults","volume":"37","author":"Fong","year":"1993","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB2","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.CIR.96.8.2573","article-title":"Thermolabile methylenetetrahydrofolate reductase in coronary artery disease","volume":"96","author":"Kluijtmans","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1161\/01.ATV.19.2.208","article-title":"Genetic analysis of the thermolabile variant of 5, 10-methylenetetrahydrofolate reductase as a risk factor for ischemic stroke","volume":"19","author":"Harmon","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1055\/s-0038-1656059","article-title":"The mutation Ala677\u2192Val in the methylene tetrahydrofolate reductase gene","volume":"77","author":"Arruda","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB5","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","article-title":"Homocysteine and atherothrombosis","volume":"338","author":"Welch","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB6","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.270.22.2693","article-title":"Vitamin status and intake as primary determinants of homocysteinemia in an elderly population","volume":"270","author":"Selhub","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB7","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1093\/jn\/126.12.3025","article-title":"Dietary intake pattern relates to plasma folate and homocysteine concentrations in the Framingham Heart Study","volume":"126","author":"Tucker","year":"1996","journal-title":"J Nutr"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/ajcn\/67.2.263","article-title":"Major lifestyle determinants of plasma total homocysteine distribution","volume":"67","author":"Nyg\u00e5rd","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ajcn\/73.3.613","article-title":"Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort","volume":"73","author":"Jacques","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB10","first-page":"536","article-title":"Thermolabile methylenetetrahydrofolate reductase","volume":"48","author":"Kang","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.nutr.19.1.217","article-title":"Homocystine metabolism","volume":"19","author":"Selhub","year":"1999","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2165\/00003495-200262040-00005","article-title":"Drugs affecting homocysteine metabolism","volume":"62","author":"Desouza","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0920-1211(00)00150-9","article-title":"Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine","volume":"41","author":"Verrotti","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0021-9150(00)00474-3","article-title":"Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia","volume":"154","author":"Giral","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1034\/j.1600-0420.2000.078003340.x","article-title":"Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion","volume":"78","author":"Larsson","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archopht.1996.01100130537006","article-title":"Risk factors for central retinal vein occlusion","volume":"114","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB18","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0161-6420(99)90357-3","article-title":"Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation","volume":"106","author":"Loewenstein","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB19","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0161-6420(00)00181-0","article-title":"Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion","volume":"107","author":"Pianka","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB20","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0002-9394(99)00476-6","article-title":"Hyperhomocysteinemia","volume":"129","author":"Vine","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1034\/j.1600-0420.2000.078005523.x","article-title":"Markers of thrombophilia in retinal vein thrombosis","volume":"78","author":"Hansen","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.84.2.154","article-title":"Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease","volume":"84","author":"Cahill","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/bjo.85.1.88","article-title":"Thermolabile MTHFR genotype and retinal vascular occlusive disease","volume":"85","author":"Cahill","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(01)00842-9","article-title":"Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age","volume":"109","author":"Lahey","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0161-6420(01)00923-X","article-title":"Homocysteine","volume":"109","author":"Brown","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00417-002-0431-9","article-title":"Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion","volume":"240","author":"Weger","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB27","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.161.13.1589","article-title":"Hyperhomocysteinemia","volume":"161","author":"Knekt","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/archinte.160.4.422","article-title":"Blood levels of homocysteine and increased risks of cardiovascular disease","volume":"160","author":"Christen","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB29","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(99)03383-8","article-title":"An alternative view of homocysteine","volume":"354","author":"Dudman","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0002-9149(97)89213-2","article-title":"Serial measures of plasma homocyst(e)ine after acute myocardial infarction","volume":"77","author":"Egerton","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ophtha.2003.08.028_BIB31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1161\/01.STR.26.5.795","article-title":"Plasma homocysteine in the acute and convalescent phases after stroke","volume":"26","author":"Lindgren","year":"1995","journal-title":"Stroke"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642003017275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642003017275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T01:53:32Z","timestamp":1585792412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642003017275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0161642003017275"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2003.08.028","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}